MGBase Launch Paper Now Published
The MGBase registry launch paper is a landmark initiative bringing together deidentified clinical data from over 1,200 MG patients across 15 countries. Built on the proven MSBase platform, this collaborative research tool enables long-term insights into treatment outcomes, disease progression, and global variations in care. Backed by Myasthenia Alliance Australia, MGBase is helping researchers and clinicians worldwide drive evidence-based improvements for people living with MG.
Explore the MGBase Launch Paper:
